TYSABRI natalizumab 300mg/15 mL concentrate for infusion vial

Biogen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c3afcb1954f711e7
Product Name: TYSABRI natalizumab 300mg/15 mL concentrate for infusion vial
Artg Id: 112372
Artg Name: TYSABRI natalizumab 300mg/15 mL concentrate for infusion vial
Sponsor: Biogen Australia Pty Ltd
Company Detail Path: /organization/biogen-australia-pty-ltd
Artg Date: 2006-11-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c867a86fc1ddbad415de2ff3c50c27f1.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e5470f4f886a09e1f2184811ed58deab.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 28, 2025

Approval ID

c3afcb1954f711e7

Type

Standard